FDA evaluating cancer link in Parkinson's drug | PD Online Research
Links shared publicly online about this topic.
- 1,270total visits
FDA evaluating cancer link in Parkinson's drug | PD Online Research
View full resource at pdonlineresearch.org
Tags: Cancer, Prostate Cancer, Prostate, Drug, Men's Health, FDA
Most Recently Shared on April 2, 2010 at 4:28 pm By:
FDA evaluating report of increased prostate cancer in the STRIDE-PD trial http://bit.ly/aO1V11
Health Highlights: July 22, 2011 - US News and World Report
health.usnews.com — “USDA Proposes Changes for Meat Additive Labeling FDA Evaluating Some Osteoporosis Drugs for Possible Cancer Link Gay Men With HIV at Increased Risk of Hepatitis C Fewer Americans See Smoking as Risky: Survey” View full resource at health.usnews.com
Most Recently Shared on July 22, 2011 at 3:55 pm By:
Healthy Child Health Organization
New additives labels proposed for meats http://j.mp/pRQ3K2 (why wouldn't ground beef be included? Pink slime?) ^js
Diabetes Drug Actos (pioglitazone) Review Initiated To Determine Possible Bladder Cancer Link - QualityPoint Technologies
qualitypointtech.net — “Actos (pioglitazone), a diabetes medication is being reviewed by the FDA (Food and Drug Administration) after it received a long-term observational study which evaluated the risk of bladder cancer. The preliminary results of the 10-year observational long-term study are based on five-year data gathered by Takeda Pharmaceuticals North America Inc., San Diego. Pioglitazone is used along with diet and exercise to control blood sugar or improve control of blood sugar in patients with Type 2 Diabetes” View full resource at qualitypointtech.net
Most Recently Shared on September 18, 2010 at 8:49 pm By:
Diabetes Drug Actos (pioglitazone) Review Initiated To Determine Possible Bladder Cancer Link: Actos (pioglitazone... http://bit.ly/aOHwmC
FDA evaluating cancer link in Parkinson's drug | Reuters
reuters.com — “NEW YORK (Reuters) - The U.S. Food and Drug Administration is evaluating clinical data that may suggest Novartis AG's Parkinson's disease treatment Stalevo is linked to an increased risk of prostate cancer. Data” View full resource at reuters.com
Most Recently Shared on April 1, 2010 at 8:54 pm By:
FDA evaluating cancer link in Parkinson's drug. http://bit.ly/90Fnls
FDA evaluating cancer link in Parkinson's drug | Reuters
reuters.com — “NEW YORK (Reuters) - The U.S. Food and Drug Administration is evaluating clinical data that may suggest Novartis AG's Parkinson's disease treatment Stalevo is linked to an increased risk of prostate cancer. Data” View full resource at reuters.com
Most Recently Shared on April 1, 2010 at 2:01 am By:
Hisham Rana, MD Doctor and Physician
FDA evaluating prostate cancer link to Parkinson's drug Stalevo (carbidopa, levodopa, entacapone) http://bit.ly/b6CN8A - #health
FDA evaluating cancer link in Parkinson's drug | Reuters
feeds.reuters.com — “NEW YORK (Reuters) - The U.S. Food and Drug Administration is evaluating clinical data that may suggest Novartis AG's Parkinson's disease treatment Stalevo is linked to an increased risk of prostate cancer. Data” View full resource at feeds.reuters.com
Most Recently Shared on March 31, 2010 at 9:21 pm By:
FDA evaluating cancer link in Parkinson's drug http://link.reuters.com/bat95j
FDA evaluating cancer link in Parkinson's drug | Reuters
feeds.reuters.com — “NEW YORK (Reuters) - The U.S. Food and Drug Administration is evaluating clinical data that may suggest Novartis AG's Parkinson's disease treatment Stalevo is linked to an increased risk of prostate cancer. Data” View full resource at feeds.reuters.com
Most Recently Shared on March 31, 2010 at 9:00 pm By:
HealthIT Policy Health News and Health IT
FDA evaluating cancer link in Parkinson's drug: NEW YORK (Reuters) - The U.S. Food and Drug Administration is eval... http://bit.ly/aaHNP9
Advertisement
